| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,483 |
3,041 |
$389K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,237 |
4,064 |
$363K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,838 |
3,458 |
$323K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
7,067 |
5,858 |
$231K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,743 |
2,330 |
$149K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,715 |
2,267 |
$68K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,355 |
1,270 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
844 |
661 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
775 |
399 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,735 |
4,512 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
161 |
96 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
130 |
115 |
$2K |
| 81025 |
|
220 |
200 |
$2K |
| 87634 |
|
25 |
22 |
$1K |
| 81003 |
|
608 |
525 |
$275.96 |
| 99000 |
|
1,560 |
1,285 |
$159.93 |
| 99072 |
|
8,236 |
6,375 |
$139.50 |
| 99070 |
|
31 |
29 |
$12.25 |
| 99051 |
|
4,705 |
4,044 |
$0.00 |